Study of Biological Effect of Tarceva (OSI-774) for Patients Stricken by ENT Epidermoid Carcinoma
Condition: Head and Neck NeoplasmsIntervention: Drug: TarcevaSponsors: Institut Claudius Regaud; Roche Pharma AGCompleted - verified May 2008
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials